First Time Loading...

Alector Inc
NASDAQ:ALEC

Watchlist Manager
Alector Inc Logo
Alector Inc
NASDAQ:ALEC
Watchlist
Price: 5.16 USD 1.38% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

ALEC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. [ Read More ]

The intrinsic value of one ALEC stock under the Base Case scenario is 11.31 USD. Compared to the current market price of 5.16 USD, Alector Inc is Undervalued by 54%.

Key Points:
ALEC Intrinsic Value
Base Case
11.31 USD
Undervaluation 54%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Alector Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ALEC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Alector Inc

Provide an overview of the primary business activities
of Alector Inc.

What unique competitive advantages
does Alector Inc hold over its rivals?

What risks and challenges
does Alector Inc face in the near future?

Has there been any significant insider trading activity
in Alector Inc recently?

Summarize the latest earnings call
of Alector Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Alector Inc.

Provide P/S
for Alector Inc.

Provide P/E
for Alector Inc.

Provide P/OCF
for Alector Inc.

Provide P/FCFE
for Alector Inc.

Provide P/B
for Alector Inc.

Provide EV/S
for Alector Inc.

Provide EV/GP
for Alector Inc.

Provide EV/EBITDA
for Alector Inc.

Provide EV/EBIT
for Alector Inc.

Provide EV/OCF
for Alector Inc.

Provide EV/FCFF
for Alector Inc.

Provide EV/IC
for Alector Inc.

Show me price targets
for Alector Inc made by professional analysts.

What are the Revenue projections
for Alector Inc?

How accurate were the past Revenue estimates
for Alector Inc?

What are the Net Income projections
for Alector Inc?

How accurate were the past Net Income estimates
for Alector Inc?

What are the EPS projections
for Alector Inc?

How accurate were the past EPS estimates
for Alector Inc?

What are the EBIT projections
for Alector Inc?

How accurate were the past EBIT estimates
for Alector Inc?

Compare the revenue forecasts
for Alector Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Alector Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Alector Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Alector Inc compared to its peers.

Compare the P/E ratios
of Alector Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Alector Inc with its peers.

Analyze the financial leverage
of Alector Inc compared to its main competitors.

Show all profitability ratios
for Alector Inc.

Provide ROE
for Alector Inc.

Provide ROA
for Alector Inc.

Provide ROIC
for Alector Inc.

Provide ROCE
for Alector Inc.

Provide Gross Margin
for Alector Inc.

Provide Operating Margin
for Alector Inc.

Provide Net Margin
for Alector Inc.

Provide FCF Margin
for Alector Inc.

Show all solvency ratios
for Alector Inc.

Provide D/E Ratio
for Alector Inc.

Provide D/A Ratio
for Alector Inc.

Provide Interest Coverage Ratio
for Alector Inc.

Provide Altman Z-Score Ratio
for Alector Inc.

Provide Quick Ratio
for Alector Inc.

Provide Current Ratio
for Alector Inc.

Provide Cash Ratio
for Alector Inc.

What is the historical Revenue growth
over the last 5 years for Alector Inc?

What is the historical Net Income growth
over the last 5 years for Alector Inc?

What is the current Free Cash Flow
of Alector Inc?

Financials

Balance Sheet Decomposition
Alector Inc

Current Assets 565.8m
Cash & Short-Term Investments 548.9m
Other Current Assets 16.9m
Non-Current Assets 56m
PP&E 47.1m
Other Non-Current Assets 9m
Current Liabilities 177.9m
Accounts Payable 3.8m
Accrued Liabilities 44.1m
Other Current Liabilities 130.1m
Non-Current Liabilities 309.7m
Other Non-Current Liabilities 309.7m
Efficiency

Earnings Waterfall
Alector Inc

Revenue
97.1m USD
Operating Expenses
-248.8m USD
Operating Income
-151.7m USD
Other Expenses
21.3m USD
Net Income
-130.4m USD

Free Cash Flow Analysis
Alector Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ALEC Profitability Score
Profitability Due Diligence

Alector Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
Declining ROE
26/100
Profitability
Score

Alector Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ALEC Solvency Score
Solvency Due Diligence

Alector Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
52/100
Solvency
Score

Alector Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALEC Price Targets Summary
Alector Inc

Wall Street analysts forecast ALEC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALEC is 14.79 USD with a low forecast of 4.04 USD and a high forecast of 43.05 USD.

Lowest
Price Target
4.04 USD
22% Downside
Average
Price Target
14.79 USD
187% Upside
Highest
Price Target
43.05 USD
734% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ALEC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ALEC Price
Alector Inc

1M 1M
-17%
6M 6M
-1%
1Y 1Y
-21%
3Y 3Y
-71%
5Y 5Y
-76%
10Y 10Y
-71%
Annual Price Range
5.16
52w Low
3.77
52w High
8.77
Price Metrics
Average Annual Return -12.42%
Standard Deviation of Annual Returns 39.34%
Max Drawdown -90%
Shares Statistics
Market Capitalization 494.1m USD
Shares Outstanding 95 750 000
Percentage of Shares Shorted 8.61%

ALEC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Alector Inc Logo
Alector Inc

Country

United States of America

Industry

Biotechnology

Market Cap

494.1m USD

Dividend Yield

0%

Description

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. The company is headquartered in South San Francisco, California and currently employs 208 full-time employees. The company went IPO on 2019-02-07. The firm is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The firm is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The firm has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.

Contact

CALIFORNIA
South San Francisco
131 Oyster Point Blvd., Suite 600
+14152315660.0
https://alector.com

IPO

2019-02-07

Employees

208

Officers

Co-Founder, CEO & Director
Dr. Arnon Rosenthal Ph.D.
President and Head of Research & Development
Dr. Sara Kenkare-Mitra Ph.D.
CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Marc Grasso M.D.
Chief Medical Officer
Dr. Gary Romano M.D., Ph.D.
Chief Scientific Officer
Mr. Peter Heutink Ph.D.
Senior Director of Corporate Communication & Investor Relations
Katie Hogan
Show More
General Counsel
Ms. Danielle Pasqualone J.D., Ph.D.
Chief People Officer
Ms. Clare Hunt M.B.A.
Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer
Ms. Kristina Cutter M.P.H.
Chief of Staff & Head of Strategy
Ms. Virginia DeJesus-Rueff M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ALEC stock?

The intrinsic value of one ALEC stock under the Base Case scenario is 11.31 USD.

Is ALEC stock undervalued or overvalued?

Compared to the current market price of 5.16 USD, Alector Inc is Undervalued by 54%.